Inmunoestimulantes para la prevención de la infección respiratoria en niños
Información
- DOI:
- https://doi.org/10.1002/14651858.CD004974.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 18 octubre 2006see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Infecciones respiratorias agudas
- Copyright:
-
- Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Dr Blanca Estela Del‐Rio‐Navarro (BN) searched for papers, extracted the relevant data, analyzed data and co‐wrote the review.
Dr Juan JL Sienra‐Monge (JSM) searched for papers, extracted the relevant data and co‐wrote the review.
Dr Francisco Espinosa‐Rosales (FER) searched for papers, analyzed data and co‐wrote the review.
Vicki Flenady (VF) co‐wrote and made corrections to the review.
Sources of support
Internal sources
-
Allergy and Clinical Immunolgy Service, Children Hospital of Mexico Federico Gomez, Mexico.
The review was supported by the local institution
External sources
-
No sources of support supplied
Declarations of interest
Dr Arturo Berber was the medical manager for OM‐85 BV (Broncho‐Vaxom) in Mexico for BASF Pharma Mexico (Química Knoll de México) from 1995 to 2001. He was also the contact author of the initial protocol until he graciously stepped down because of a potential conflict of interest.
Dr Blanca Del Rio‐Navarro and Dr Sienra‐Monge were involved in the following IS trial: Del‐Rio‐Navarro BE, Luis Sienra‐Monge JJ, Berber A, Torres‐Alcantara S, Avila‐Castanon L, Gomez‐Barreto D. Use of OM‐85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels. Allergologia et Immunopathologia (Madrid) 2003 Jan‐Feb;31(1):7‐13.
Dr Blanca Del Rio‐Navarro was involved in the following IS trials: Field J, Gomez‐Barreto D, Del‐Rio‐Navarro BE, Berber A. Use of OM‐85 BV in primary prevention of acute respiratory tract infections in children in orphanages Current Therapeutics Research, Clinical and Experimental 1998 59:6 (407‐18); Berber AC, Del‐Rio‐Navarro BE. Use of Broncho‐Vaxom in private practice: phase IV trial in 587 children. Clinical Therapeutics 1996 Nov‐Dec;18(6):1068‐79.
Acknowledgements
We especially acknowledged the great editorial work of Liz Dooley. We thank Arturo Berber for his contribution to the protocol. The authors also wish to thank the following people for commenting on the draft review of the first version: Chanpen Choprapawon, Ville Peltola, Richard Shoemaker and Ludovic Reveiz; and to Anne Lyddiatt, Ville Peltola, Sree Nair and Ludovic Reveiz for the comments on the updated draft review.
Version history
| Published | Title | Stage | Authors | Version |
| 2006 Oct 18 | Immunostimulants for preventing respiratory tract infection in children | Review | Blanca Estela Del‐Rio‐Navarro, Francisco J Espinosa‐Rosales, Vicki Flenady, Juan JL Sienra‐Monge | |
| 2004 Oct 18 | Immunostimulants for preventing respiratory tract infection in children | Protocol | Arturo Berber, Blanca Estela Del‐Rio‐Navarro, Vicki Flenady, Juan JL Sienra‐Monge | |
